Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;52(8):1937-1939.
doi: 10.1007/s10439-024-03511-2. Epub 2024 Apr 11.

Ethical Considerations of Neuralink and Brain-Computer Interfaces

Affiliations

Ethical Considerations of Neuralink and Brain-Computer Interfaces

Ethan Waisberg et al. Ann Biomed Eng. 2024 Aug.

Erratum in

Abstract

Neuralink is a neurotechnology company founded by Elon Musk in 2016, which has been quietly developing revolutionary technology allowing for ultra-high precision bidirectional communication between external devices and the brain. In this paper, we explore the multifaceted ethical considerations surrounding neural interfaces, analyzing potential societal impacts, risks, and call for a need for responsible innovation. Despite the technological, medical, medicolegal, and ethical challenges ahead, neural interface technology remains extremely promising and has the potential to create a new era of medicine.

Keywords: Brain-computer interface; Brain-machine; Invasive; Microimplants; Neural interface; Neural prosthesis; Neurology; Neurosurgery; Neurotechnology; Ophthalmology.

PubMed Disclaimer

Similar articles

References

    1. Neuralink, Musk E. An Integrated Brain-Machine Interface Platform With Thousands of Channels. J Med Internet Res. 21(10):16194, 2019. https://doi.org/10.2196/16194 - DOI
    1. Neuralink livestream shows paralyzed person playing chess on laptop. NBC News. Published March 20, 2024. Accessed March 23, 2024. https://www.nbcnews.com/tech/tech-news/neuralink-livestream-shows-paraly...
    1. Griffin A. Elon Musk says he is curing blindness with brain computer chips. Published March 21, 2024. Accessed March 23, 2024. https://www.independent.co.uk/tech/elon-musk-neuralink-brain-blindsight-...
    1. Kelly A. U.S. regulators rejected Elon Musk’s bid to test brain chips in humans, citing safety risks. Reuters. Published March 2, 2023. Accessed March 26, 2024. https://www.reuters.com/investigates/special-report/neuralink-musk-fda/
    1. Alser, M., and E. Waisberg. Concerns with the usage of ChatGPT in Academia and Medicine: A viewpoint. American Journal of Medicine Open. 2023. https://doi.org/10.1016/j.ajmo.2023.100036 . - DOI

LinkOut - more resources